English
Kopran Q1 Results
- BSE: 524280
- NSE: KOPRAN
- ISIN: INE082A01010
- Sector: Biotechnology & Drugs
BSE
157.95
-2.15 (-1.34%)
-2.15 (-1.34%)Volume8.84 K
Updated: Fri 7 Nov, 2025 | 15:42:27
NSE
158.46-1.96 (-1.22%)
-1.96 (-1.22%)Volume1.90 L
Updated: Fri 7 Nov, 2025 | 15:44:41
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹135.22 Cr.(-3.03%)
- Operating Profit₹9.87 Cr.(-30.92%)
- Profit After Tax₹7.45 Cr.(-32.86%)
- Operating Margin7.30%(-28.76%)
Note: Comparison is on YoY basis
Quarterly - Kopran Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 125.34 | 158.35 | -20.84% | 125.15 | 0.16% |
| Depreciation/ Amortization | 4.26 | 3.87 | 10.09% | 3.87 | 9.95% |
| Operating Income | 9.87 | 14.02 | -29.57% | 14.29 | -30.92% |
| Net Income | 7.45 | 9.68 | -23.02% | 11.10 | -32.86% |
| Other Operating Expenses Total | 20.25 | 21.85 | -7.35% | 22.03 | -8.07% |
| Net Income Before Taxes | 9.89 | 13.71 | -27.88% | 14.73 | -32.88% |
| Total Revenue | 135.22 | 172.36 | -21.55% | 139.44 | -3.03% |
| Selling/ General/ Admin Expenses Total | 15.43 | 17.26 | -10.60% | 13.35 | 15.62% |
| Diluted Normalized EPS | 1.54 | 2.00 | -23.11% | 4.60 | -66.52% |